The Intracranial Pressure Monitoring (ICP) market has witnessed significant growth in recent years, driven by an increasing prevalence of neurological disorders and traumatic brain injuries. ICP monitoring plays a crucial role in assessing and managing intracranial pressure, providing valuable insights for medical professionals to make informed decisions.
The Intracranial Pressure Monitoring Market is anticipated to reach USD 4 billion by 2032 at 6.9% CAGR during the forecast period 2023-2032.
ICP monitoring involves the use of specialized devices to measure the pressure inside the skull. These devices are designed to accurately gauge the pressure exerted by the cerebrospinal fluid on the brain, helping healthcare providers in diagnosing and treating conditions such as traumatic brain injuries, brain tumors, and hydrocephalus.
One of the key factors fueling the demand for ICP monitoring is the rising incidence of head injuries and neurological disorders globally. As awareness about the importance of early detection and monitoring of intracranial pressure increases, the adoption of ICP monitoring devices is expected to surge.
The ICP monitoring market encompasses a variety of devices, including intraventricular catheters, subarachnoid bolts, and epidural sensors. These devices are essential for real-time monitoring of intracranial pressure levels, enabling timely intervention and improved patient outcomes. The continuous advancements in technology have led to the development of more sophisticated and minimally invasive ICP monitoring devices, enhancing their accuracy and reliability.
Hospitals and trauma centers are the primary end-users of ICP monitoring devices, given their critical role in managing patients with traumatic brain injuries. Additionally, the increasing geriatric population, prone to neurological disorders, contributes to the expanding market for ICP monitoring devices.
Major Key Players:
Leading players in the global Intracranial-Pressure Monitoring Companies are DePuy Synthes, Terumo Corporation, Spiegelberg GmbH Co. KG, RAUMEDIC Inc., Boston Neurosciences, Medtronic plc, Integra LifeSciences Corporation, Sophysa SA, and Natus Medical Inc.
Segment Analysis
The global intracranial pressure (ICP) monitoring market can be segmented on the basis of route of intervention, technique, device, application, end user, and region.
By route of intervention, the global intracranial pressure monitoring market is segmented into intraventricular and epidural sensor.
By technique, the market is segmented into invasive and non-invasive. The former is segmented into microtransducer ICP monitoring and external ventricular drainage (EVD), while the latter is sub-segmented into transcranial doppler ultrasonography, tympanic membrane displacement (TMD) analyzer, optic nerve sheath diameter sonography, fundoscopy (papilladema), and MRI/CT.
Devices offered in the intracranial pressure monitoring market include intraventricular catheter, subarachnoid screw, epidural sensors, and non-invasive ICP monitors.
Key applications include traumatic brain injury, intracerebral hemorrhage, subarachnoid hemorrhage, and meningitis.
Major end users of ICP monitoring include hospitals clinics and trauma centers.
Regional Analysis
Americas held a dominant 41.4% share in the global ICP monitoring device market in 2017 and are likely to hold on to the lead in the global intracranial pressure monitoring market over the forecast period due to the increasing demand for effective intracranial pressure monitoring devices in North America. Widespread awareness about the importance of intracranial pressure monitoring in North America, particularly the U.S. and Canada, is likely to remain a major driver for the intracranial pressure monitoring market in the Americas over the forecast period. Intracranial pressure monitoring is mainly used in the management of brain trauma and skeletal hemorrhage. The rising prevalence of both these target conditions in North America is likely to remain a major driver for the intracranial pressure monitoring market in the region over the forecast period.
Europe is also likely to hold a significant share in the global intracranial pressure monitoring market over the forecast period due to the increasing awareness about the process and the relevance of the monitoring in medical diagnosis and trauma management. Intensive efforts at trauma control and management in European countries are likely to be a major driver for the intracranial pressure monitoring market in the region over the forecast period. The growing demand for noninvasive intracranial pressure monitoring tools in Europe and North America is also likely to be a major driver for the market, as the healthcare sector in these advanced regions is transitioning towards noninvasive medical tests, leading to a corresponding increase in the demand for noninvasive tools and technologies from the medical devices sector. Despite the increasing awareness about the inefficacy of noninvasive testing in intracranial pressure monitoring, the demand for product innovations aiming at making noninvasive intracranial pressure monitoring more accurate and on par with invasive monitoring is likely to remain a major driver for the intracranial pressure monitoring market in North America and Europe over the forecast period.
Browse Related Reports:
Pharmaceutical Excipients Market
For More Information, Please Visit @ Market Research Future
